Julie Gerberding - Insider Trading & Ownership

Location
2000 Galloping Hill Road, Kenilworth, NJ
Summary
The estimated net worth of Julie Gerberding is at least $5.92M dollars as of September 17, 2025. Julie Gerberding is the EVP, Chief Patient Officer of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $5.82M. Julie Gerberding is the Director of MCKESSON CORP and owns shares of MCKESSON CORP (MCK) stock worth about $101K.
Signature
/s/ Paul Bavier, Attorney-in-Fact for Julie Gerberding
All Insider Reports
All Insider Reports

Ownership of Julie Gerberding

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRK Merck & Co., Inc. EVP, Chief Patient Officer $5.82M Feb 24, 2022
MCK MCKESSON CORP Director $101K Jul 30, 2025
HLVX HilleVax, Inc. Director $0 Sep 17, 2025
AFTR AfterNext HealthTech Acquisition Corp. Director Aug 11, 2021
CERN CERNER Corp Director Jun 7, 2022

Insider Transactions Reported by Julie Gerberding:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.